Caley Sullivan

Caley Sullivan currently serves as Head of Innovation at eemagine Medical Imaging Solutions GmbH since January 2024 and holds a Research Affiliate position at The Australian National University. As Regional Director and CEO of ANT Neuro Australia Pty Ltd since March 2021, Caley also established RTx | Resonance Therapeutics as Founder and CEO in January 2019. Additionally, Caley has experience as a Research Officer Technology at Epworth until May 2024 and has been affiliated with Monash University since June 2014. Previous roles include participation in The BridgeTech Program and serving as a Research Assistant at Alfred Health from April 2014 to January 2019. Academic qualifications include a Bachelor of Science with Honours in Biomedical Sciences from the University of Melbourne and dual Bachelor degrees in Arts (Psychology) and Science from The University of Queensland.